Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 27826
Evènement :International Cannabinoid Derived Pharmaceuticals Summit

Dates :Lundi 10 Décembre 2018 - Mercredi 12 Décembre 2018

Lieu :Hyatt Regency Boston
1 Avenue de Lafayette
02111 Boston, États-Unis

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

With 17+ hours of content, we will be tackling the key issues from the benchside to commercialization. By considering a range of therapeutic areas, the conference is designed exclusively for the Cannabinoid drug developer. Our speakers will discuss complex Cannabinoid pharmacology, formulations, clinical trials, patient education and commercial challenges.

URLs:
Tickets: https://go.evvnt.com/267417-0?pid=4319
Brochure: https://go.evvnt.com/267417-2?pid=4319

Time: 8:00 am - 6:00 pm

Prices:
Conference Only: GBP 1999.0,
Conference + 2 Workshops: GBP 2897.0

Speakers: Chris Bunka, Chairman of the Board and Chief Executive Officer, Lexaria Biosciences, Tamás Biro, Professor, Research Center for Molecular Medicine Departments of Immunology and Physiology, University of Debrecen, Le Roy Dowey, Head of Corporate Development, Greenlight Medicines, Vincenzo di Marzo, Canada Excellence Research Chair, Université Laval and Research Director, CNR, Sazzad Hossain, CEO Entourage Biosciences / CSO, Inmed Pharmaceuticals Inc, Allyn Howlett, Professor, Wake Forest University, Gary Hiller, Chief Operations Officer and President, Phytecs, Catherine Jacobson, Director of Clinical Research, Tilray, Zohar Koren, Chief Executive Officer and Founder, SciCann, Shimon Lecht, Chief of Research and Development CannRx, Arnold Lippa, Executive Chairman and Chief Scientific Officer, RespireRx Pharmaceuticals, Jeff Eliot Margolis, Senior Vice President, Chief Financial Officer, Treasurer, Secretary, member of the Board of Directors, RespireRx Pharmaceuticals, Soumyajit Majumdar, Professor of Pharmaceutics and Drug Delivery, University of Mississippi, Brian Murphy, Chief Executive Officer and Chief Medical Officer, Nemus Bioscience, Inc, Richard Purcell, Senior Vive President, RespireRx, Dan Peer, Chair, Tel Aviv University Cancer Biology Research Center; Managing Director, Center for Translational Medicine, Jutta Roth, Chief Scientific Officer, Oxford Cannabinoid Technologies, Andrea Small- Howard, Chief Scientific Officer, GB Sciences, Adi Zulloff-Shani, Chief Technology Officer, Therapix

Lieu

Plan et itinéraire
Adresse de la conférence :
Hyatt Regency Boston
1 Avenue de Lafayette
02111 Boston
États-Unis
Plan et itinéraire

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

International Cannabinoid Derived Pharmaceuticals Summit Pharmacie
--
Tout public
-- -- --
English

Divers

Pour plus d'informations sur International Cannabinoid Derived Pharmaceuticals Summit, veuillez contacter Hanson Wade

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama


Recommander cet évènement